Quest Diagnostics Incorporated
DGX
$168.48
$0.62630.37%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.11% | 1.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.11% | 1.18% | |||
| Cost of Revenue | 1.96% | 1.60% | |||
| Gross Profit | 8.52% | 0.35% | |||
| SG&A Expenses | 4.75% | 0.87% | |||
| Depreciation & Amortization | 0.00% | 5.41% | |||
| Other Operating Expenses | 300.00% | -150.00% | |||
| Total Operating Expenses | 2.63% | 1.38% | |||
| Operating Income | 13.32% | 0.00% | |||
| Income Before Tax | 33.67% | -3.29% | |||
| Income Tax Expenses | 64.41% | -13.24% | |||
| Earnings from Continuing Operations | 25.96% | -0.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 6.67% | -7.14% | |||
| Net Income | 28.18% | -0.90% | |||
| EBIT | 13.32% | 0.00% | |||
| EBITDA | 10.24% | 0.99% | |||
| EPS Basic | 27.16% | -0.45% | |||
| Normalized Basic EPS | 18.66% | -4.77% | |||
| EPS Diluted | 27.32% | -2.12% | |||
| Normalized Diluted EPS | 19.73% | -4.76% | |||
| Average Basic Shares Outstanding | 0.90% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | 0.00% | 6.67% | |||
| Payout Ratio | -0.16% | 0.01% | |||